Senior insider sale
TRANSPHORM, INC. — senior position signals high conviction
$44.8K
9.23K shares
What this filing means
SMALES KELLY plans to sell 9.23K shares of TRANSPHORM, INC. valued at approximately $44.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/22/2024ACC: 0001970051-24-000036
9.23K
Shares to sell
$44.8K
Approx. market value
4K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Common Stock
COMPENSATORY PAYMENT
10/11/2023
4KTotal acquired4K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/11/2023 | Common Stock COMPENSATORY PAYMENT | 4K | — |
| Total | 4K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
475.00
Market value
$2.3K
4/24/2024
—Completed
Units to sell
766.00
Market value
$3.8K
4/4/2024
—Completed
Units to sell
4K
Market value
$19.2K
2/28/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
4K
Market value
$19.5K
5/22/2024
Total
Units
9.23K
Value
$44.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/24/2024 | 475.00 | $2.3K | — | Completed |
4/4/2024 | 766.00 | $3.8K | — | Completed |
2/28/2024 | 4K | $19.2K | — | Completed |
| Planned — Approximate Date | ||||
5/22/2024 | 4K | $19.5K | NASDAQ | Planned |
| Total | 9.23K | $44.8K | ||